The increasing attention being paid by researchers to studies in the field of stereoselective synthesis and catalysis, as well as methods of chromatographic separation of chiral phases, observed over the last decade, is due to the requirements of the World Health Organization for the optical purity of drugs. The lack of universally applicable chiral phases for separating optical isomers prompts researchers to develop new sorbents. Immobilized macrocyclic glycopeptide antibiotics (including vancomycin, teichoplanin, ristocetin A, avoparcin, etc.) proved to serve as chiral phases for reliable HPLC separation of a wide range of drugs [1][2][3][4]. The high enantioselectivity of the sorbents belonging to this class is due to the presence of structurally diverse fragments capable of multiple-point interactions with the compounds to be separated (in both polar and nonpolar solvents). Immobilization of new antibiotics [5], chemical modifications of their structure [6], and refinement of immobilization techniques [7] offer additional possibilities for changing the enantioselectivity of sorbents belonging to this class.It was previously shown that eremomycin (a new antibiotic manufactured in Russia), in contrast to its closest structural analogue vancomycin, exhibits high enantioselectivity in separating isomers of α amino acids when immobilized on silica gel [8]. A method of its immobilization was developed that increased the selectivity of the separation, thus, rendering the sorbent superior to other chiral selectors in separating isomers of α amino acids [9].In this work, we sought to explore the capacity of the new eremomycin sorbent for separating enantiomers of other classes (profens) and study the effects of structural modification of eremomycin on its enantioselectivity, as compared to the known chiral selectors vancomycin and ristomycin.
MATERIALS AND METHODSReagents. The antibiotics were immobilized using modified silica gels: Diaspher-110-Epoxy (particle size, 6 µ m; specific surface, 313 m 2 /g; pore diameter, 11 nm; carbon content, 5.2%) and Diasorb-130-Epoxy (particle size, 6 µ m; specific surface, 280 m 2 /g; pore diameter, 13 nm; carbon content, 4.8%) manufactured by BioChemMack ST Russia. The eluants were prepared using methanol, acetic acid, and triethylamine (Fluka, Switzerland). Eremomycin and ristomycin were synthesized using a pilot plant at the Hause Institute for New Antibiotics (Russia) [10,11]. Vancomycin was provided by the joint stock company Veropharm (Russia). The profens and amino acids were purchased from Sigma (United States).Obtaining eremosaminyl aglycon of eremomycin [4]. Eremomycin (3 g) was dissolved in 30 ml of dimethyl sulphoxide, and the solution was supplemented with 2 ml of 80% sulfuric acid, after which the mixture Kuznetsov a , P. N. Nesterenko a , G. G. Vasiyarov a , and S Abstract -Chiral sorbents for HPLC separation of optical isomers carrying glycopeptide antibiotics (eremomycin or its eremosaminyl aglycon, ristomycin, or vancomycin) fixed onto the surface of silica gel...